ArticleReumatologia2023

Multicenter evaluation of tofacitinib retention and safety in rheumatoid arthritis - why cardiovascular risk factors do not equate to overt risk.

Anna Felis-Giemza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.